Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00001816
Other study ID # 990105
Secondary ID 99-C-0105
Status Completed
Phase N/A
First received November 3, 1999
Last updated March 3, 2008
Start date May 1999
Est. completion date February 2001

Study information

Verified date May 2000
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

This study seeks to evaluate the impact of Starbright World (SBW) on hospitalized children. SBW is a virtual environment designed to link seriously ill children into an interactive online community where they can play games, learn about their condition, or talk with other ill children who are connected to the network. Our outcome evaluation of SBW will include assessments of pain, mood (anxious, depressed and energetic), anger, loneliness, and willingness to return to the NIH for treatment of children who are being treated at NIH. They will be assessed while engaging in "normal" recreational activities (in one of two available playrooms) and while using Starbright World. In addition, we will conduct a process evaluation of the implementation of Starbright World.


Description:

This study seeks to evaluate the impact of Starbright World (SBW) on hospitalized children. SBW is a virtual environment designed to link seriously ill children into an interactive online community where they can play games, learn about their condition, or talk with other ill children who are connected to the network. Our outcome evaluation of SBW will include assessments of pain, mood (anxious, depressed and energetic), anger, loneliness, and willingness to return to the NIH for treatment of children who are being treated at the NIH. They will be assessed while engaging in "normal" recreational activities (in one of two available playrooms) and while using Starbright World. In addition, we will conduct a process evaluation of the implementation of Starbright World.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date February 2001
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Children between the ages of 8 and 21.

Currently on active protocol at NIH.

Access to playrooms on the 9th, 11th, 13th, and 14th floors.

Ability to read and understand English.

No presence of mental illness.

Ability to understand and/or perform tasks involved in using Starbright World.

Study Design

N/A


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Cancer Institute (NCI) Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990 May;41(2):139-50. — View Citation

Brennan PF, Moore SM, Smyth KA. The effects of a special computer network on caregivers of persons with Alzheimer's disease. Nurs Res. 1995 May-Jun;44(3):166-72. — View Citation

Izenberg N, Lieberman DA. The Web, communication trends, and children's health. Part 4: How children use the Web. Clin Pediatr (Phila). 1998 Jun;37(6):335-40. — View Citation

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Completed NCT02769598 - Pain Management in Pediatric Intensive Care by Studying the Autonomic Balance N/A
Completed NCT02625142 - Family-Centered Rounds Checklist Implementation N/A
Completed NCT04275336 - Pharmacological and Non-pharmacological Interventions in Management of Venipuncture Pain. N/A
Withdrawn NCT05545319 - A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 Phase 2
Recruiting NCT05275543 - Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab N/A